Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders Health Condition 2: F488- Other specified nonpsychotic mental disorders
Conditions
Interventions
None listed
Sponsors
CSMSS AYURVED MAHAVIDYALAYA AND RUGNALAYA KANCHANWADI
Eligibility
Inclusion criteria
Inclusion criteria: Patients showing lakshanas of Chittodvega - 1.Chinta (fearful Anticipation/worries) 2.Bhay (Feeling of Tension/ Restlessness/Any type of Fear) 3.Nidralpata (Insomnia/unsatisfying sleep and fatigue on waking/night terrors) 4.AnawasthitChitta (Difficulty in concentration/ poor memory) 5.Anichha (loss of interest/ low feeling/depression) 6.Hrutspadandan (chest pain/ palpitation/ throbing of vessels) 7.AshpataVakpravrutti (unsteady voice/ grinding of teeth) 8.Daurbalya (weakness) 9.Shwaskashtata( dyspnea/ breathing difficulty) 10.Udarshool(Abdominal pain/ Abdominal fullness/Anoexia/ bowel alteration) 11.Bahumutrata(urgrncy& frequency of micturation) 12.Mukhshushkata (dry mouth/ swallowing difficulty/pallor) 13.Atiswedpravrutti(excessive sweating) 14.Kamp (tremors of hands and legs/fidgeting/ strained face) 3.Patients willing to participate in the trial. 4.Patients were selected according to Hamilton’s Anxiety Rating Scale.
Exclusion criteria
Exclusion criteria: 1.Age below 18 years and above 60 years. 2.Patients showing signs and symptoms other than Anxiety neurosis. 3.Known cases of Endocrine, Metabolic, Carcinoma’s, and Systemic disorders (Cushing syndrome, Addison’s Disease, Hashimoto disorder, Pancreatic disorder, Gonadal disorders, PCOD, PCOS or any Gynecological disorders, Adrenal Hyperplasia , Severe Insulin resistance (Diabetes Mellitus) , Androgen secreting tumor , Carcinoma of any gland, Coronary Heart Diseases, Respiratory &Hepatic diseases, Ulcerative Colitis, Chronic kidney disorders) 4.Known cases of Mental disorders like Depression, Alzheimer, Schizophrenia, Mania, Epilepsy , Obsessive compulsive disorder. 5.A Current or Previous (Within 3 month) use of Antipsychotic drugs, Antidepressant drugs, Antiepileptic drugs or any Hormonal Therapy. 6.Pregnant & lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome of the trial will be updated after completion of study.Timepoint: 2 years. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome of the trial will be updated after completion of study.Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactDr Yashashri Arun Vitonde
Chhatrapati Shahu Maharaj Shikshan Sansthas Ayurved Mahavidyalaya and Rugnalaya
Outcome results
None listed